TICKER COVERAGE
$GH
3 long-form articles and 0 pre-market mentions covering $GH from AskMelon Research.
3 articles
FEATURE
Guardant Health races to $1.3B in revenue while losses keep widening past $110M a quarter
Guardant Health books the fastest revenue growth of its public life — 48% in the first quarter of 2026, screening revenue up more than 600% on its Shield blood test — and the market has rewarded the s…
FEATURE
Tempus AI grows revenue 36% to $348M yet GAAP losses widen to $126M
Tempus AI sells the most seductive story in healthcare: an "intelligent diagnostics" platform where every blood draw trains an algorithm and every algorithm sharpens the next draw — a genomics flywhee…
FEATURE
Abbott's $21 billion Exact Sciences buyout cashed out a never-profitable growth story at $105
The bears spent a decade circling Exact Sciences with the same indictment: real revenue, real growth, and never a clean GAAP profit, all riding on a single stool-based colon-cancer test about to be fl…